BiographyAditya Bardia MD, MPH, completed his Internal Medicine residency training at Mayo Clinic and oncology fellowship at Johns Hopkins Kimmel Cancer Center. Dr. Bardia is interested in developing predictive biomarkers and algorithms to maximize efficacy and minimize harms of therapeutic agents and thus personalize therapies for breast cancer. This includes evaluation of large databases to identify potential biomarkers, as well as conduct of biomarker driven clinical trials to evaluate blood based biomarkers (such as circulating tumor cells) and tissue based biomarkers (such as gene signatures) to predict response (or lack thereof) of a particular chemotherapy or targeted therapy. Dr. Bardia is the recipient of Young Investigator Award from the ASCO Conquer Cancer Foundation.
Phone 2: 617-643-0744